Competitors: | Renalytix (Reg S), SDI Group |
Registrars: | Capita Registrars |
CEO: | David Marsh |
CFO & Executive Director: | Chris Martin |
Chairman: | Jonathan Glenn |
Independent Non-Executive Director: | Keyvan Djamarani |
Non-Executive Dir: |
Address: | Clayton Wood House, Clayton Wood Bank Rise, Leeds, United Kingdom, LS16 6QZ |
Phone: | +44 (0) 113 230 7597 |
Fax: | +44 (0) 113 230 7598 |
Website: | http://www.sigroupplc.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB0004016704 |
Currency | UK Pounds |
Share Price | 0.55p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 0.90p |
52 Week Low | 0.40p |
Volume | 60,000 |
Shares Issued | 932.82m |
Market Cap | £5.13m |
Beta | 0.52 |
RiskGrade | 341 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
CEO | David Marsh |
Chair | Jonathan Glenn |
You are here: research